Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/14/2019 10/15/2019 10/16/2019 10/17/2019 10/18/2019 Date
310.31(c) 312.17(c) 309.67(c) 310.55(c) 309.44(c) Last
766 845 624 770 657 467 595 213 592 494 Volume
+2.55% +0.60% -0.80% +0.28% -0.36% Change
More quotes
Financials (USD)
Sales 2019 3 524 M
EBIT 2019 986 M
Net income 2019 951 M
Finance 2019 2 663 M
Yield 2019 -
Sales 2020 4 014 M
EBIT 2020 1 205 M
Net income 2020 1 006 M
Finance 2020 3 413 M
Yield 2020 -
P/E ratio 2019 48,0x
P/E ratio 2020 46,4x
EV / Sales2019 12,2x
EV / Sales2020 10,5x
Capitalization 45 488 M
More Financials
Company
Illumina specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and... 
More about the company
Surperformance© ratings of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA, INC.
10/09ILLUMINA, INC. : Report
CO
10/08ILLUMINA : to Announce Third Quarter 2019 Financial Results on Thursday, October..
BU
10/08Qiagen CEO quits amid genetic sequencing U-turn, shares tumble
RE
10/03ILLUMINA, INC. : Report
CO
10/01ILLUMINA, INC. : Report
CO
09/30ILLUMINA : and Broad Institute Announce Agreement to Co-Develop Genomic Secondar..
BU
09/26ILLUMINA, INC. : Entry into a Material Definitive Agreement, Financial Statement..
AQ
09/25ILLUMINA, INC. : SEC Filing 8K
CO
09/23ILLUMINA : Names Joydeep Goswami Senior Vice President of Corporate Development ..
BU
09/16ILLUMINA, INC. : Report
CO
09/12ILLUMINA : Recommends Stockholders Reject Mini-Tender Offer by TRC Capital Corpo..
BU
09/05ILLUMINA, INC. : Report
CO
08/29ILLUMINA, INC. : SEC Filing 8K
CO
08/29ILLUMINA, INC. : Report
CO
08/19ILLUMINA, INC. : Report
CO
More news
News in other languages on ILLUMINA, INC.
07/29EN DIRECT DES MARCHES : Sanofi, Airbus, Air France KLM, CNP, Refinitiv, Mylan..
07/12Records à Wall Street où on espère toujours une baisse des taux
07/12Les valeurs à suivre aujourd'hui à Wall Street Vendredi 12 juillet 2019
07/12ILLUMINA : le chiffre d'affaires déçoit
07/12WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Stock Trading Strategies
ILLUMINA - 2018
Underpinned by a support level
BUY
More Stock Trading Analysis
Sector news : Advanced Medical Equipment & Technology - NEC
10/17INTUITIVE SURGICAL : Beats Wall Street 3Q Targets
DJ
10/15Eaton to Sell Lighting Business to Signify in $1.4 Billion Deal
DJ
10/10EUROPE : European shares rise on Brexit, trade deal hopes; LVMH shines
RE
10/10ROYAL PHILIPS : ADRs Down 8% After 3Q Forecast
DJ
10/10Castleton Technology Shares Dive After Profit Warning; ProPhotonix Awarded Fi..
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 328,63  $
Last Close Price 309,44  $
Spread / Highest target 22,8%
Spread / Average Target 6,20%
Spread / Lowest Target -14,7%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Robert P. Ragusa Senior Vice President-Global Quality & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.3.17%45 488
THERMO FISHER SCIENTIFIC25.75%112 770
DANAHER CORPORATION33.83%98 832
INTUITIVE SURGICAL, INC.18.23%61 015
BOSTON SCIENTIFIC CORPORATION8.86%53 170
EDWARDS LIFESCIENCES CORPORATION48.50%47 375